BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Esme P, Akoglu G, Caliskan E. Rapid Response to Certolizumab Pegol in Hidradenitis Suppurativa: A Case Report. Skin Appendage Disord 2021;7:58-61. [PMID: 33614722 DOI: 10.1159/000511284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Scala E, Cacciapuoti S, Garzorz-Stark N, Megna M, Marasca C, Seiringer P, Volz T, Eyerich K, Fabbrocini G. Hidradenitis Suppurativa: Where We Are and Where We Are Going. Cells 2021;10:2094. [PMID: 34440863 DOI: 10.3390/cells10082094] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Repetto F, Burzi L, Ramondetta A, Rozzo G, Licciardello M, Ribero S, Quaglino P, Dapavo P. Certolizumab pegol and its role in pregnancy-age hidradenitis suppurativa. Int J Dermatol 2021. [PMID: 34270087 DOI: 10.1111/ijd.15742] [Reference Citation Analysis]